ZA894392B - Pharmaceutical products - Google Patents
Pharmaceutical productsInfo
- Publication number
- ZA894392B ZA894392B ZA894392A ZA894392A ZA894392B ZA 894392 B ZA894392 B ZA 894392B ZA 894392 A ZA894392 A ZA 894392A ZA 894392 A ZA894392 A ZA 894392A ZA 894392 B ZA894392 B ZA 894392B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydrogen
- nrr
- azido
- pharmaceutical products
- synergistic
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229960000329 ribavirin Drugs 0.000 abstract 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Formation And Processing Of Food Products (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20516388A | 1988-06-10 | 1988-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA894392B true ZA894392B (en) | 1990-08-29 |
Family
ID=22761073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA894392A ZA894392B (en) | 1988-06-10 | 1989-06-09 | Pharmaceutical products |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0346132B1 (OSRAM) |
| JP (1) | JPH0291022A (OSRAM) |
| AT (1) | ATE73335T1 (OSRAM) |
| AU (1) | AU627188B2 (OSRAM) |
| DE (1) | DE68900961D1 (OSRAM) |
| DK (1) | DK284189A (OSRAM) |
| GR (1) | GR3004628T3 (OSRAM) |
| NZ (1) | NZ229453A (OSRAM) |
| ZA (1) | ZA894392B (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175292A (en) * | 1988-01-20 | 1992-12-29 | Regents Of The University Of Minnesota | Intermediates for the preparation of dideoxycarbocyclic nucleosides |
| US5631370A (en) * | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
| GB2243609B (en) * | 1988-01-20 | 1992-03-11 | Univ Minnesota | Dideoxydidehydrocarbocyclic pyrimidines |
| IE62275B1 (en) * | 1988-01-20 | 1995-01-25 | Univ Minnesota | Dideoxydidehydrocarbocyclic nucleosides |
| GB8815265D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
| US4939252A (en) * | 1989-04-20 | 1990-07-03 | Hoffmann-La Roche Inc. | Novel intermediates for the preparation of Carbovir |
| EP0879056B1 (en) * | 1996-01-23 | 2002-05-02 | ICN Pharmaceuticals, Inc. | Modulation of th1/th2 cytokine expression by ribavirin in activated t-lymphocytes |
| EP0998293A4 (en) * | 1997-01-17 | 2002-07-17 | Icn Pharmaceuticals | TREATMENTS FOR CYTOKIN-RELATED DISEASES |
| GB9721780D0 (en) * | 1997-10-14 | 1997-12-10 | Glaxo Group Ltd | Process for the synthesis of chloropurine intermediates |
| US5916594A (en) * | 1997-12-22 | 1999-06-29 | Schering Corporation | Process of making solid ribavirin dosage forms |
| MY119656A (en) * | 1997-12-22 | 2005-06-30 | Schering Corp | Orally administrable solid ribavirin dosage forms and process for making them |
| GB9903091D0 (en) * | 1999-02-12 | 1999-03-31 | Glaxo Group Ltd | Therapeutic nucleoside compound |
| US7638496B2 (en) | 2000-02-15 | 2009-12-29 | Valeant Pharmaceuticals North America | Nucleoside analogs with carboxamidine modified monocyclic base |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| EA007867B1 (ru) | 2000-05-26 | 2007-02-27 | Айденикс (Кайман) Лимитед | Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения |
| ATE314851T1 (de) * | 2002-06-27 | 2006-02-15 | Medivir Ab | Synergistische wechselwirkung von abacavir und alovudin |
| NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| MXPA05005192A (es) | 2002-11-15 | 2005-09-08 | Idenix Cayman Ltd | Nucleosidos ramificados en la posicion 2' y mutacion de flaviviridae. |
| WO2006122003A2 (en) * | 2005-05-05 | 2006-11-16 | Ardea Biosciences, Inc. | Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
| US7968521B2 (en) | 2005-06-24 | 2011-06-28 | Yamasa Corporation | Stable cystal of protected pseudouridine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4138562A (en) * | 1977-02-09 | 1979-02-06 | The Regents Of The University Of Minnesota | Adenosine deaminase resistant antiviral purine nucleosides and method of preparation |
| US4362729A (en) * | 1980-06-23 | 1982-12-07 | The Regents Of The University Of Minnesota | Alkoxyalkanoate esters of cyclaradine |
| US4636383A (en) * | 1984-08-29 | 1987-01-13 | Schering Corporation | Interferon-cyclaradine combination |
| DE58902899D1 (de) * | 1988-12-14 | 1993-01-14 | Ciba Geigy Ag | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer. |
-
1989
- 1989-06-08 NZ NZ229453A patent/NZ229453A/xx unknown
- 1989-06-09 AT AT89305829T patent/ATE73335T1/de not_active IP Right Cessation
- 1989-06-09 DK DK284189A patent/DK284189A/da not_active Application Discontinuation
- 1989-06-09 EP EP89305829A patent/EP0346132B1/en not_active Expired - Lifetime
- 1989-06-09 DE DE8989305829T patent/DE68900961D1/de not_active Expired - Lifetime
- 1989-06-09 JP JP1145534A patent/JPH0291022A/ja active Pending
- 1989-06-09 ZA ZA894392A patent/ZA894392B/xx unknown
- 1989-06-09 AU AU36272/89A patent/AU627188B2/en not_active Ceased
-
1992
- 1992-05-18 GR GR920400957T patent/GR3004628T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0346132A1 (en) | 1989-12-13 |
| DK284189D0 (da) | 1989-06-09 |
| DK284189A (da) | 1989-12-11 |
| GR3004628T3 (OSRAM) | 1993-04-28 |
| NZ229453A (en) | 1991-08-27 |
| AU627188B2 (en) | 1992-08-20 |
| EP0346132B1 (en) | 1992-03-11 |
| ATE73335T1 (de) | 1992-03-15 |
| JPH0291022A (ja) | 1990-03-30 |
| DE68900961D1 (de) | 1992-04-16 |
| AU3627289A (en) | 1989-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA894392B (en) | Pharmaceutical products | |
| CA2100269A1 (en) | Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B | |
| IL93050A0 (en) | Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL101883A0 (en) | Antiviral combinations and pharmaceutical compositions containing them | |
| AU640137B2 (en) | Novel arylpyridazines, their manufacture, use and medicaments containing them | |
| AU6858791A (en) | Uracil derivatives and pesticides containing the same as active ingredient | |
| IL101544A0 (en) | Pyrazolopyridine derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
| AU8693491A (en) | Synergism of hiv reverse transcriptase inhibitors | |
| EP0522173A4 (en) | 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof | |
| PH30732A (en) | Dideoxydide-hydrocarbocyclic nucleosides. | |
| EP0412940A3 (en) | Hydantoin or imidazolidinetrione derivatives for the prevention or treatment of renal failure | |
| AU5491194A (en) | Cytotoxic and antiviral compound | |
| EP0509098A4 (en) | Ataractic | |
| IE780530L (en) | Anti-histamine salts and compositions |